Scarica l'app Stockscreener
0.9017
7.61%
0.0638
Dopo l'orario di chiusura:
.93
0.0283
+3.14%
Precedente Chiudi:
$0.8379
Aprire:
$0.86
Volume 24 ore:
421.18K
Relative Volume:
0.11
Capitalizzazione di mercato:
$214.05M
Reddito:
-
Utile/perdita netta:
$-14.33M
Rapporto P/E:
-1.3662
EPS:
-0.66
Flusso di cassa netto:
$-13.21M
1 W Prestazione:
+19.45%
1M Prestazione:
-11.60%
6M Prestazione:
-30.64%
1 anno Prestazione:
-23.58%
Intervallo 1D:
$0.8432
$0.94
Intervallo di 1 settimana:
$0.755
$0.94
Portata 52W:
$0.66
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Nome
Enlivex Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ENLV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
0.9017 | 198.90M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-02 | Reiterato | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Borsa (ENLV) Ultime notizie
VIX Spike: How Enlivex Therapeutics Ltd. stock reacts to bond yieldsQuarterly Market Summary & Breakout Confirmation Trade Signals - ulpravda.ru
Why Enlivex Therapeutics Ltd. stock could outperform in 2025Market Sentiment Review & Capital Efficient Trading Techniques - ulpravda.ru
Will Enlivex Therapeutics Ltd. stock rally after Fed decisionsEarnings Summary Report & Safe Entry Momentum Stock Tips - ulpravda.ru
Aug Wrap: How Enlivex Therapeutics Ltd. stock reacts to bond yieldsPortfolio Gains Report & Real-Time Market Trend Scan - ulpravda.ru
Tangible book value per share of Enlivex Therapeutics Ltd. – LSX:A119KH - TradingView — Track All Markets
Is Enlivex Therapeutics Ltd. stock oversold or undervaluedJuly 2025 Sentiment & Technical Buy Zone Confirmation - ulpravda.ru
Los Angeles Daily NewsEnlivex Therapeutics Ltd.Ordinary Shares (Nasdaq:ENLV) Stock Quote - FinancialContent
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enlivex Therapeutics (ENLV) Lists RAIN Token on KuCoin - GuruFocus
Enlivex Lists RAIN Treasury Token on KuCoin to Deepen Liquidity and Market Access - TipRanks
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange - The Manila Times
Crypto token tied to real-world prediction markets just hit KuCoin - Stock Titan
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun
Is Rashi Peripherals Limited Stock a Safe LongTerm Investment Data BreakdownSupport Level Holds & Low Cost Capital Trading - earlytimes.in
Free cash flow per share of Enlivex Therapeutics Ltd. – SWB:1BT - TradingView — Track All Markets
Enlivex Therapeutics (NASDAQ:ENLV) Downgraded by Wall Street Zen to “Strong Sell” - Defense World
Energy Moves: Why Enlivex Therapeutics Ltd. stock could outperform in 2025Market Activity Summary & Fast Gain Stock Trading Tips - Улправда
What valuation multiples suggest for Enlivex Therapeutics Ltd. stockQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - Улправда
Why hedge funds are buying Enlivex Therapeutics Ltd. stockMarket Trend Summary & Safe Capital Growth Stock Tips - Улправда
Enlivex Calls February 2026 Extraordinary Meeting to Approve Governance Changes and Reverse Share Split - The Globe and Mail
Levels Update: Will Enlivex Therapeutics Ltd. stock deliver consistent dividendsJuly 2025 Snapshot & Weekly High Return Stock Forecasts - Улправда
Enlivex Therapeutics schedules extraordinary general meeting for February By Investing.com - Investing.com Nigeria
Enlivex Therapeutics schedules extraordinary general meeting for February - Investing.com
Enlivex Therapeutics (NASDAQ: ENLV) schedules Extraordinary General Meeting in Israel - Stock Titan
Earnings Beat: Will Enlivex Therapeutics Ltd. stock deliver consistent dividendsQuarterly Growth Report & Fast Exit and Entry Strategy Plans - Улправда
Enlivex Therapeutics Ltd (ENLV) stock: A year of ups and downs - uspostnews.com
Enlivex Therapeutics (ENLV) price target decreased by 30.00% to 7.14 - MSN
Enlivex: A Necessary UpdateThis Is No Longer The Company We Covered In 2022 (NASDAQ:ENLV) - Seeking Alpha
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
An analyst sees good growth prospects for Enlivex Therapeutics Ltd (ENLV) - setenews.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Enlivex announces fireside chat on RAIN token and Allocetra development - MSN
Enlivex Announces Fireside Chat on RAIN Token and Allocetra Development - TipRanks
Enlivex Therapeutics Ltd. Announces Virtual Fireside Chat to Discuss Digital Asset Strategy and Clinical Development Plans - Quiver Quantitative
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development - marketscreener.com
How Enlivex Therapeutics Ltd. stock reacts to oil pricesTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser
Enlivex Therapeutics Ltd Azioni (ENLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):